Title: Thermo Fisher Scientific Inc. (TMO) 10K Annual Reports & 10Q SEC Filings
URL: https://last10k.com/sec-filings/tmo

HOME


LOGIN


PREMIUM


FREE TRIAL


SEC FILINGS


STOCK SCREENERS


EARNINGS


TRENDING


STOCKTWITS


INSIDER TRADING


SENTIMENT ANALYSIS


MANAGER PORTFOLIOS


LATE CORPORATE NEWS






				 



Thermo Fisher Scientific Inc. (TMO) SEC Filing 10-K Annual Report for the fiscal year ending Sunday, December 31, 2023


Home
SEC Filings
Thermo Fisher Scientific Inc. (TMO)
10-K Annual Report Thu Feb 22 2024






SEC Filings



 
TMO Valuations





Intrinsic Value





Financial Stability





Financial Ratios





Insider Trades





Manager Portfolios





Notifications





 
TMO Annual Reports
				  





10-K Annual Report February 2024


PDF

PDF


Select PDF Feature:
Include Exhibits
Highlight YoY Changes
Highlight Sentiment

10-K Only


Word
Excel
CSV


Table of Contents
Business
Risk Factors
Unresolved Staff Comments
Cybersecurity
Properties
Legal Proceedings
Mine Safety Disclosures
Market for the Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Reserved
Managements Discussion and Analysis of Financial Condition and Results of Operations
Quantitative and Qualitative Disclosures About Market Risk
Financial Statements and Supplementary Data
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Controls and Procedures
Other Information
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Directors, Executive Officers and Corporate Governance
Executive Compensation
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Certain Relationships and Related Transactions, and Director Independence
Principal Accountant Fees and Services
Exhibits and Financial Statement Schedules
Form 10K Summary








									10-K Annual Report February 2023																






									10-K Annual Report February 2022																






									10-K Annual Report February 2021																






									10-K Annual Report February 2020																






									10-K Annual Report February 2019																






									10-K Annual Report February 2018																






									10-K Annual Report February 2017																






									10-K Annual Report February 2016																






TMO Quarterly Reports
				  





									10-Q Quarterly Report August 2024																






									10-Q Quarterly Report May 2024																






									10-Q Quarterly Report November 2023																






									10-Q Quarterly Report August 2023																






									10-Q Quarterly Report May 2023																






									10-Q Quarterly Report November 2022																






									10-Q Quarterly Report August 2022																






									10-Q Quarterly Report May 2022																






									10-Q Quarterly Report August 2021																






									10-Q Quarterly Report May 2021																






TMO Corporate News
				  





									Earnings ReleaseFinancial Exhibit																	October 2024







									Earnings ReleaseFinancial Exhibit																	July 2024







									Financial ExhibitOther Events																	July 2024







									Vote of Security Holders																	May 2024







									Earnings ReleaseFinancial Exhibit																	April 2024







									Earnings ReleaseFinancial Exhibit																	January 2024







									Financial ExhibitNew AgreementOther Events																	December 2023







									Employee BenefitsFinancial Exhibit																	November 2023







									Earnings ReleaseFinancial Exhibit																	October 2023







									Financial ExhibitOther Events																	October 2023













Last10K.com | 10-K Annual Report Thu Feb 22 2024






Thermo Fisher Scientific Inc.


													CIK: 97745
																										Ticker: TMO




Earnings Press Release
 10-K Annual Report
 10-K YoY Changes
 Annual Proxy




Thermo Fisher Scientific Inc.

HISTORY
TOOLS


CIK: 97745
Ticker: TMO




Exhibit 99.1NewsFOR IMMEDIATE RELEASEMedia Contact Information:Sandy PoundInvestor Contact Information:Rafael TejadaThermo Fisher ScientificThermo Fisher ScientificPhone: 781-622-1223Phone: 781-622-1356E-mail: sandy.pound@thermofisher.comE-mail: rafael.tejada@thermofisher.comThermo Fisher Scientific Reports Fourth Quarter 2023 ResultsWALTHAM, Mass. (January 31, 2024) – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2023.Fourth Quarter and Full Year 2023 Highlights•Fourth quarter revenue was $10.89 billion, 5% lower versus the same quarter last year. Core organic revenue growth declined 4%.•Fourth quarter GAAP diluted EPS was $4.20, 5% higher versus the same quarter last year, driven by 70 basis points of operating margin expansion.•Fourth quarter adjusted EPS was $5.67, 5% higher versus the same quarter last year, driven by 100 basis points of adjusted operating margin expansion.•Full year revenue was $42.86 billion, 5% lower versus prior year. Core organic revenue growth was 1%.•Full year GAAP diluted earnings per share (EPS) was $15.45.•Full year adjusted EPS was $21.55.•During the year, we strengthened our industry leadership, advanced our trusted partner status with our customers, and delivered differentiated financial performance for our shareholders due to strong execution by our global team enabled by our PPI Business System.•Advanced our proven growth strategy, launching a range of high-impact, innovative new products during the year, highlighted by the groundbreaking Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer, the Applied Biosystems™ QuantStudio™ Absolute Q™ AutoRun dPCR System, the Thermo Scientific™ Metrios™ 6 S/TEM, the first FDA-cleared assays for risk assessment and clinical management of preeclampsia, and the Gibco™ CTS™ Detachable Dynabeads™. During the quarter, we launched the Thermo Scientific™ Meridian™ EX System, an electron-beam-based solution for precise defect localization in advanced logic semiconductors and the Thermo Scientific™ Aquanex™ Ultrapure Water Purification System, for reliable water purity and operational enhancement in laboratories.•Continued to further strengthen our industry-leading commercial engine and deepen our trusted partner status during the year, as demonstrated by our differentiated performance in 2023. This included the addition of a new customer excellence center in Europe, partnering and collaborating with customers on innovative new medicines, and leveraging The following information was filed by Thermo Fisher Scientific Inc. (TMO) on Wednesday, January 31, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release. 

Please wait while we load the requested 10-K report or click the link below:https://last10k.com/sec-filings/report/97745/000009774524000007/tmo-20231231.htm


View differences made from one year to another to evaluate Thermo Fisher Scientific Inc.'s financial trajectory





Sample 10-K Year-over-Year (YoY) Comparison



Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Thermo Fisher Scientific Inc..

Continue







Assess how Thermo Fisher Scientific Inc.'s management team is paid from their Annual Proxy





Screenshot example of actual Proxy Statement




Thermo Fisher Scientific Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors


Continue














SEC Filing Tools




 Sentiment
 Sections
 Exhibits
 Stats


 



 Rating					
Learn More










Filter Sentiment:



All






Positive




Negative





Filter Category:




All






Legal





Financial







M & A






Revenue






Other






Filter Subcategory:




All






Cash Flow






Expense






Debt






Income






Product






Dividend






Geography





Earnings







Shares






Other







 Inside Thermo Fisher Scientific Inc.'s 10-K Annual Report:


 Legal - Other   Highlight
Changes in tax laws, regulations, agreements and treaties, currency exchange restrictions or the company’s level of operations or profitability in each taxing jurisdiction could have an impact upon the amount of current and deferred tax balances and hence the company’s net income.



 Other - Other   Highlight
Should tax return positions that the company expects are sustainable not be sustained upon audit, the company could be required to record an incremental tax provision for such taxes.

 Other - Other   Highlight
The diagnostics and healthcare market declined due to decreased demand for COVID-19 testing products.

 Financial - Cash Flow   Highlight
Actual cash flows arising from a particular intangible asset could vary from projected cash flows, which could imply different carrying values from those established at the dates of acquisition and which could result in impairment of such asset.

 Financial - Expense   Highlight
We exclude these costs because we do not believe they are indicative of our normal operating costs.

 Other - Other
Events or circumstances that might...Read more

 Financial - Debt
Adjusted results in 2022 also...Read more

 Other - Other
There can be no assurance,...Read more

 Financial - Expense
We exclude these costs because...Read more

 Legal - Other
•The noncontrolling interest and tax...Read more

 M & A - Other
The acquisition expands the segment’s...Read more

 Financial - Income
We report adjusted operating income,...Read more

 Financial - Income
dispersion of the company’s non-U.S....Read more

 Other - Other
The company estimates the degree...Read more

 Other - Other
This was partially offset by...Read more

 Financial - Income
The increase in segment income...Read more

 Other - Other
As of December 31, 2023, no...Read more

 Legal - Other
The company operates in numerous...Read more

 Other - Other
We exclude these items because...Read more

 Revenue - Product
The increase in organic revenues...Read more

 Legal - Other
The company is contingently liable...Read more

 Revenue - Product
During 2023, sales growth in...Read more

 Financial - Cash Flow
The company’s proven growth strategy...Read more

 Other - Other
The company performed the quantitative...Read more

 Financial - Income
On an on-going basis, management...Read more

 M & A - Other
On January 3, 2023, the...Read more

 Other - Other
We saw broad based strength...Read more

 Financial - Dividend
In addition, the company also...Read more

 M & A - Other
The company uses assumptions and...Read more

 Revenue - Product
Increases in accounts receivable and...Read more

 Other - Other
If the company borrows under...Read more

 Other - Other
Additionally, our pharma services business...Read more

 Other - Other
Adjusted results in 2023 also...Read more

 M & A - Other
•Certain acquisition-related costs, including charges...Read more

 Other - Other
These increases were partially offset...Read more

 Other - Other
Thermo Fisher Scientific Inc. enables...Read more

 Financial - Cash Flow
The company estimates the fair...Read more

 Other - Other
The industrial and applied market...Read more

 Financial - Income
The increase in segment income...Read more

 Revenue - Product
The increase in organic revenues...Read more

 Other - Other
There were no interim impairments...Read more

 Revenue - Geography
The company uses its non-U.S....Read more

 Revenue - Product
Adjusted results in 2022 also...Read more

 M & A - Other
During 2023, acquisitions of The...Read more

 Financial - Income
The increase in segment income...Read more

 Other - Other
The company has operations and...Read more

 Revenue - Product
Thermo Fisher management uses organic...Read more

 Other - Other
In 2023, reduced demand for...Read more

 M & A - Other
The acquisition expands the segment’s...Read more

 M & A - Other
On August 14, 2023, the...Read more

 Financial - Income
The company assesses income tax...Read more

 Other - Other
At February 22, 2024, $1.00 billion...Read more

 M & A - Other
The company deploys its capital...Read more

 M & A - Other
Adjusted results in 2023 also...Read more

 Other - Other
Markets served include pharmaceutical and...Read more

 Other - Other
During its annual 2023 goodwill...Read more

 Other - Other
Repayment of senior notes and...Read more

 Other - Other
Management bases its estimates on...Read more

 Revenue - Product
The decrease in organic revenues...Read more

 Other - Other
Repayment of senior notes and...Read more

 Other - Other
On November 14, 2023, the...Read more

 Financial - Income
In the ordinary course of...Read more

 Financial - Income
The company’s ability to obtain...Read more

 Other - Other
Most of the company’s definite-lived...Read more

 M & A - Other
Since the company’s acquisition of...Read more

 Other - Other
The company’s investing activities also...Read more

 Other - Other
Over the past few years,...Read more

 Financial - Cash Flow
Estimates of discounted future cash...Read more

 Financial - Expense
(c)   Adjusted results...Read more

 Revenue - Product
Sales of products related to...Read more

 Other - Other
Such measures are also used...Read more

 Other - Other
For those tax positions where...Read more

 Financial - Cash Flow
The company reviews these definite-lived...Read more

 Financial - Cash Flow
Different assumptions from those made...Read more

 Revenue - Product
revenue recognition methods under the...Read more

 Revenue - Product
Determinations of fair value based...Read more

 Other - Other
The reporting unit had $3.95...Read more

 Financial - Cash Flow
The company believes that its...Read more

 Other - Other
Since 2020, the Life Sciences...Read more

 Revenue - Product
(a)    Adjusted...Read more

 Other - Other
Actual results may differ from...Read more

 Financial - Income
In situations in which the...Read more

 Revenue - Product
Contributions to organic revenue during...Read more

 Financial - Cash Flow
We report free cash flow,...Read more

 Financial - Income
During 2022, cash provided by...Read more

 Revenue - Product
The biosciences and bioproduction businesses...Read more

 Financial - Expense
Despite this favorable increase, given...Read more

 Financial - Income
During 2023, cash provided by...Read more

 Other - Other
In these situations, the company...Read more

 Other - Other
Should the fair values of...Read more

 Financial - Income
Due primarily to the non-deductibility...Read more

 Financial - Cash Flow
Free cash flow is not...Read more

 Financial - Income
A decrease in accounts payable...Read more

 M & A - Other
Exclusion of the amortization expense...Read more

 Other - Other
As a result of using...Read more

 Revenue - Product
The preparation of these financial...Read more

 Revenue - Product
The decrease in organic revenues...Read more

 Financial - Income
Should the company’s actual future...Read more

 Other - Other
These positive impacts continued at...Read more

 Other - Other
The company evaluates goodwill and...Read more

 Financial - Income
Determination of taxable income in...Read more

 Revenue - Product
We report organic revenue growth...Read more

 Financial - Expense
We estimate that restructuring actions...Read more

 Other - Other
The results of these estimates...Read more

 Other - Other
Adjusted results in 2022 also...Read more

 Financial - Cash Flow
The projected cash flows are...Read more

 Financial - Expense
•Costs/income associated with restructuring activities...Read more

 Other - Other
During 2022 the company’s investing...Read more

 Financial - Income
The decrease in segment income...Read more

 Revenue - Product
investments, the sale of businesses,...Read more

 Financial - Expense
(b)   Adjusted results...Read more

 Financial - Cash Flow
Approximately half of the company’s...Read more

 M & A - Other
•The expense associated with the...Read more

 Other - Other
If it becomes more likely...Read more

 Financial - Earnings
The effective tax rates in...Read more

 Financial - Income
The effective tax rate can...Read more

 Financial - Shares
Weighted average diluted shares decreased...Read more

 Financial - Income
For those income tax positions...Read more

 Other - Other
The company expects that for...Read more



 
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report





Audit Information





Cover





Consolidated Balance Sheet





Consolidated Balance Sheet (Parenthetical)





Consolidated Statement Of Cash Flows





Consolidated Statement Of Comprehensive Income





Consolidated Statement Of Comprehensive Income (Parenthetical)





Consolidated Statement Of Income





Consolidated Statement Of Redeemable Noncontrolling Interest And Equity





Consolidated Statement Of Redeemable Noncontrolling Interest And Equity (Parenthetical)





Acquisitions





Acquisitions (Tables)





Acquisitions - Narrative (Details)





Acquisitions - Schedule Of Components Of Purchase Price (Details)





Acquisitions - Schedule Of Pro Forma Information (Details)





Business Segment And Geographical Information





Business Segment And Geographical Information (Tables)





Business Segment And Geographical Information - Schedule Of Revenue By Geographical Areas (Details)





Business Segment And Geographical Information - Schedule Of Segment Reporting Information (Details)





Commitments And Contingencies





Commitments And Contingencies (Details)





Comprehensive Income And Shareholders Equity





Comprehensive Income And Shareholders Equity (Tables)





Comprehensive Income And Shareholders' Equity (Details)





Debt And Other Financing Arrangements





Debt And Other Financing Arrangements (Tables)





Debt And Other Financing Arrangements - Narrative (Details)





Debt And Other Financing Arrangements - Schedule Of Annual Repayment Requirements For Debt Obligations (Details)





Debt And Other Financing Arrangements - Schedule Of Debt (Details)





Earnings Per Share





Earnings Per Share (Tables)





Earnings Per Share - Schedule Of Earnings Per Share, Basic And Diluted (Details)





Fair Value Measurements And Fair Value Of Financial Instruments





Fair Value Measurements And Fair Value Of Financial Instruments (Tables)





Fair Value Measurements And Fair Value Of Financial Instruments - Rollforward Of The Fair Value Of Investments (Details)





Fair Value Measurements And Fair Value Of Financial Instruments - Schedule Of Aggregate Notional Value And Fair Value Of Derivative Instruments (Details)





Fair Value Measurements And Fair Value Of Financial Instruments - Schedule Of Carrying Value And Fair Value Of The Company's Debt Instruments (Details)





Fair Value Measurements And Fair Value Of Financial Instruments - Schedule Of Derivative Instruments, Gain (Loss) Recognized (Details)





Fair Value Measurements And Fair Value Of Financial Instruments - Schedule Of Financial Assets And Liabilities Measured At Fair Value (Details)





Income Taxes





Income Taxes (Tables)





Income Taxes - Components Of Income Before Provision For Income Taxes And Provision For Income Taxes (Details)





Income Taxes - Narrative (Details)





Income Taxes - Reconciliation Of Unrecognized Tax Benefits (Details)





Income Taxes - Schedule Of Deferred Tax Asset (Liability) And Changes In Valuation Allowance (Details)





Income Taxes - Schedule Of Effective Income Tax Rate Reconciliation (Details)





Insider Trading Arrangements





Leases





Leases (Tables)





Leases - Schedule Of Future Payments Of Operating Lease Liabilities (Details)





Leases - Schedule Of Operating Leases (Details)





Leases- Narrative (Details)





Nature Of Operations And Summary Of Significant Accounting Policies





Nature Of Operations And Summary Of Significant Accounting Policies (Policies)





Nature Of Operations And Summary Of Significant Accounting Policies (Tables)





Nature Of Operations And Summary Of Significant Accounting Policies - Acquisition-Related Intangible Assets (Details)





Nature Of Operations And Summary Of Significant Accounting Policies - Additional Accounting Policy And Balance Sheet Disclosures (Details)





Nature Of Operations And Summary Of Significant Accounting Policies - Goodwill (Details)





Nature Of Operations And Summary Of Significant Accounting Policies - Inventories (Details)





Nature Of Operations And Summary Of Significant Accounting Policies - Property, Plant And Equipment (Details)





Nature Of Operations And Summary Of Significant Accounting Policies - Recent Accounting Pronouncements (Details)





Other Income/Expense





Other Income/Expense (Details)





Pension And Other Postretirement Benefit Plans





Pension And Other Postretirement Benefit Plans (Tables)





Pension And Other Postretirement Benefit Plans - Accumulated And Projected Benefit Obligation And Fair Value Of Plan Assets (Details)





Pension And Other Postretirement Benefit Plans - Schedule Of Estimated Future Benefit Payments (Details)





Pension And Other Postretirement Benefit Plans - Schedule Of Fair Value Of The Company's Plan Assets (Details)





Pensions And Other Postretirement Benefit Plans - Actuarial Assumptions (Details)





Pensions And Other Postretirement Benefit Plans - Narrative (Details)





Pensions And Other Postretirement Benefit Plans - Reconciliation Of Benefit Obligations And Plan Assets (Details)





Restructuring And Other Costs





Restructuring And Other Costs (Tables)





Restructuring And Other Costs - Schedule Of The Company's Accrued Restructuring Balance (Details)





Restructuring And Other Costs - Schedule Of The Company's Accrued Restructuring Balance (Details)





Revenue &Amp; Contract-Related Balances - Contract Assets And Liabilities (Details)





Revenue &Amp; Contract-Related Balances - Disaggregation Of Revenue (Details)





Revenue &Amp; Contract-Related Balances - Revenue Performance Obligations (Details)





Revenue And Contract-Related Balances





Revenue And Contract-Related Balances (Tables)





Stock-Based Compensation Expense





Stock-Based Compensation Expense (Tables)





Stock-Based Compensation Expense - Narrative (Details)





Stock-Based Compensation Expense - Schedule Of Weighted Average Assumptions Used In The Black-Scholes Option Pricing Model (Details)





Stock-Based Compensation Expense - Summary Of The Company's Option Activity (Details)





Stock-Based Compensation Expense - Summary Of The Company's Restricted Unit Activity (Details)





Supplemental Cash Flow Information





Supplemental Cash Flow Information (Tables)





Supplemental Cash Flow Information - Schedule Of Cash, Cash Equivalents And Restricted Cash (Details)





Supplemental Cash Flow Information - Schedule Of Supplemental Cash Flow Disclosures (Details)




 
Material Contracts, Statements, Certifications & more
Thermo Fisher Scientific Inc. provided additional information to their SEC Filing as exhibits





Exhibit 3.4: Amended And Restated By-Laws Of The Registrant





Exhibit 10.1: Amended And Restated Deferred Compensation Plan For Directors





Exhibit 10.49: Amended And Restated Deferred Compensation Plan





Exhibit 21: Subsidiaries Of The Registrant





Exhibit 22: Subsidiary Issuer Of Guaranteed Securities





Exhibit 23.1: Consent Of Pricewaterhousecoopers Llp





Exhibit 31.1: Certification





Exhibit 31.2: Certification





Exhibit 32.1: Certification





Exhibit 32.2: Certification





Exhibit 97: Clawback Policy






Ticker: TMO CIK: 97745
Form Type: 10-K Annual Report
Accession Number: 0000097745-24-000007
Submitted to the SEC: Thu Feb 22 2024 1:06:42 PM EST
Accepted by the SEC: Thu Feb 22 2024
Period:  Sunday, December 31, 2023
Industry: Measuring And Controlling Devices						
External Resources:
 Stock Quote
 Social Media
 SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/tmo/0000097745-24-000007.htm








About 
											Contact 
											Help 
											API 
											Privacy 
											Terms 
									


© 2012 - 2024 Last10K.com All Rights Reserved









×
You're Signed Out
Sign in for the full experience


Sign in
Join Now








Intrinsic Value Calculator








Screenshot of intrinsic value for AT&T (2019)




Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
Continue












Never Miss A New SEC Filing Again








Screenshot taken from Gmail for a new 10-K Annual Report




Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news
Continue












We Highlighted This SEC Filing For You








Screenshot taken from Wynn's 2018 10-K Annual Report




Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q
Continue












Widen Your SEC Filing Reading Experience








Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report




Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view
Continue












Uncover Actionable Information Inside SEC Filings








Screenshot taken from Lumber Liquidators 10-K Annual Report




Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
Continue












Adobe PDF, Microsoft Word, Excel and CSV Downloads








Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats




Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), Excel (XLSX) and Comma-Delimited (CSV) files for offline viewing, annotations and analysis
Continue












Adobe PDF, Microsoft Word, Excel and CSV Downloads








Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats




Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), Excel (XLSX) and Comma-Delimited (CSV) files for offline viewing, annotations and analysis
Continue












Financial Stability Report








Screenshot of financial stability report for Coco-Cola (2019)




Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
Continue












Get a Better Picture of a Company's Performance








Available Financial Ratios




Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years
Continue












See when company executives buy or sell their own stock








Screenshot taken from Euronet (EEFT)




Last10K.com Member Feature

Use our calculated cost dollar values to discover when and how much registered owners BUY, SELL or excercise their company stock OPTIONS aggregated from Form 4 Insider Transactions SEC Filings
Continue












See how institutional managers trade a stock








Screenshot taken from General Motors (GM)




Last10K.com Member Feature

View which hedge funds, pension / retirement funds, endowments, banks and insurance companies have increased or decreased their positions in a particular stock. Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more
Continue












FREE Financial Statements








Screenshot of actual balance sheet from company 10-K Annual Report




Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREE












SEC Filing Exhibit
 PDF Download



Loading SEC Filing Exhibit...








SEC Filing Financial Summary
 PDF Download
 Excel Download



Loading SEC Filing Financial Summary...

